Ben Kahn1,2, Zachary Freeland1,2, Purva Gopal3, Deepak Agrawal1,2, Christian A Mayorga1,2, Rozina Mithani1,2, Celette Sugg Skinner4,5, Ethan A Halm1,2,4, Amit G Singal6,7,8,9,10. 1. Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA. 2. Parkland Health & Hospital System, Dallas, TX, USA. 3. Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. 4. Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX, USA. 5. Harold C. Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. 6. Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA. amit.singal@utsouthwestern.edu. 7. Parkland Health & Hospital System, Dallas, TX, USA. amit.singal@utsouthwestern.edu. 8. Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX, USA. amit.singal@utsouthwestern.edu. 9. Harold C. Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. amit.singal@utsouthwestern.edu. 10. Division of Digestive and Liver Diseases, University of Texas Southwestern, 5959 Harry Hines Blvd, POB 1, Suite 420, Dallas, TX, 75390-8887, USA. amit.singal@utsouthwestern.edu.
Abstract
PURPOSE: Appropriate surveillance intervals for colorectal cancer (CRC) screening is one of the Centers for Medicare and Medicaid Services 2014 physician quality reporting system measures. Appropriateness of surveillance intervals will continue to be monitored closely, particularly as reimbursements become tied to quality measures. AIMS: Quantify and identify predictors for guideline-concordant surveillance recommendations after adenoma polypectomy. METHODS: We conducted a retrospective cohort study of patients who had colonoscopy with polypectomy at a safety-net health system between June 2011 and December 2013. Surveillance recommendations shorter and longer than guideline recommendations were defined as potential overuse and underuse. We used multivariate logistic regression to identify correlates of guideline-concordant surveillance recommendations, overuse, and underuse. RESULTS: Among 1,822 patients with polypectomy, 1,329 had ≥1 adenoma. Surveillance interval recommendations were guideline-concordant in 1,410 (77.4%) patients, potential overuse in 263 (14.4%), potential underuse in 85 (4.7%), and missing in 64 (3.5%) patients. Predictors of guideline-concordant recommendations in multivariate analyses included age >65 years (OR 1.36, 95% CI 1.02-1.80), incomplete resection (OR 3.58, 95% CI 1.41-9.09), and good/excellent prep quality (OR 2.22, 95% CI 1.72-2.86). Underuse recommendations were more likely in patients with ≥3 adenomas; overuse recommendations were more likely in patients with high-grade dysplasia or fair prep quality and less likely in those with piecemeal resection, ≥3 adenomas, age >65, or Hispanic ethnicity. CONCLUSIONS: Surveillance recommendations are not concordant with guidelines in one of four cases. Interventions to improve prep quality and guideline concordance of surveillance recommendations can improve cost-effectiveness of CRC screening.
PURPOSE: Appropriate surveillance intervals for colorectal cancer (CRC) screening is one of the Centers for Medicare and Medicaid Services 2014 physician quality reporting system measures. Appropriateness of surveillance intervals will continue to be monitored closely, particularly as reimbursements become tied to quality measures. AIMS: Quantify and identify predictors for guideline-concordant surveillance recommendations after adenoma polypectomy. METHODS: We conducted a retrospective cohort study of patients who had colonoscopy with polypectomy at a safety-net health system between June 2011 and December 2013. Surveillance recommendations shorter and longer than guideline recommendations were defined as potential overuse and underuse. We used multivariate logistic regression to identify correlates of guideline-concordant surveillance recommendations, overuse, and underuse. RESULTS: Among 1,822 patients with polypectomy, 1,329 had ≥1 adenoma. Surveillance interval recommendations were guideline-concordant in 1,410 (77.4%) patients, potential overuse in 263 (14.4%), potential underuse in 85 (4.7%), and missing in 64 (3.5%) patients. Predictors of guideline-concordant recommendations in multivariate analyses included age >65 years (OR 1.36, 95% CI 1.02-1.80), incomplete resection (OR 3.58, 95% CI 1.41-9.09), and good/excellent prep quality (OR 2.22, 95% CI 1.72-2.86). Underuse recommendations were more likely in patients with ≥3 adenomas; overuse recommendations were more likely in patients with high-grade dysplasia or fair prep quality and less likely in those with piecemeal resection, ≥3 adenomas, age >65, or Hispanic ethnicity. CONCLUSIONS: Surveillance recommendations are not concordant with guidelines in one of four cases. Interventions to improve prep quality and guideline concordance of surveillance recommendations can improve cost-effectiveness of CRC screening.
Authors: David A Lieberman; Douglas K Rex; Sidney J Winawer; Francis M Giardiello; David A Johnson; Theodore R Levin Journal: Gastroenterology Date: 2012-07-03 Impact factor: 22.682
Authors: Laura C Seeff; Thomas B Richards; Jean A Shapiro; Marion R Nadel; Diane L Manninen; Leslie S Given; Fred B Dong; Linda D Winges; Matthew T McKenna Journal: Gastroenterology Date: 2004-12 Impact factor: 22.682
Authors: Douglas K Rex; John L Petrini; Todd H Baron; Amitabh Chak; Jonathan Cohen; Stephen E Deal; Brenda Hoffman; Brian C Jacobson; Klaus Mergener; Bret T Petersen; Michael A Safdi; Douglas O Faigel; Irving M Pike Journal: Am J Gastroenterol Date: 2006-04 Impact factor: 10.864
Authors: Gregory S Cooper; Tzuyung D Kou; Jill S Barnholtz Sloan; Siran M Koroukian; Mark D Schluchter Journal: Cancer Date: 2013-02-21 Impact factor: 6.860
Authors: J Sint Nicolaas; V de Jonge; O van Baalen; F J G M Kubben; W Moolenaar; M F J Stolk; E J Kuipers; M E van Leerdam Journal: Endoscopy Date: 2013-04-11 Impact factor: 10.093
Authors: Robert E Schoen; Paul F Pinsky; Joel L Weissfeld; Lance A Yokochi; Douglas J Reding; Richard B Hayes; Timothy Church; Susan Yurgalevich; V Paul Doria-Rose; Tom Hickey; Thomas Riley; Christine D Berg Journal: Gastroenterology Date: 2009-10-08 Impact factor: 22.682
Authors: Melissa Magrath; Edward Yang; Chul Ahn; Christian A Mayorga; Purva Gopal; Caitlin C Murphy; Samir Gupta; Deepak Agrawal; Ethan A Halm; Eric K Borton; Celette Sugg Skinner; Amit G Singal Journal: J Natl Compr Canc Netw Date: 2018-11 Impact factor: 11.908
Authors: Amit G Singal; Samir Gupta; Celette Sugg Skinner; Chul Ahn; Noel O Santini; Deepak Agrawal; Christian A Mayorga; Caitlin Murphy; Jasmin A Tiro; Katharine McCallister; Joanne M Sanders; Wendy Pechero Bishop; Adam C Loewen; Ethan A Halm Journal: JAMA Date: 2017-09-05 Impact factor: 56.272